Overexpression, purification, and characterization of full-length and mutant caldesmons using a baculovirus expression system
- PMID: 7706421
- DOI: 10.1007/BF00121072
Overexpression, purification, and characterization of full-length and mutant caldesmons using a baculovirus expression system
Abstract
Three recombinant chicken gizzard caldesmon (CaD) baculovirus vectors that contained the full-length CaD codon sequence (Pv1CaD), the full-length CaD codon sequence and a six-histidine tag at the 5'-end (pBlueBacHisCaD), or the full-length CaD codon sequence and an extra six-histidine codon sequence at the 3'-end (PvlHisCaD) were constructed. Spodoptera frugiperda (Sf9) cells transfected with these constructs overexpressed full-length CaD, yielding 2, 20, and 50 micrograms per 10(6) cells for pBlueBacHisCaD, PvlHisCaD, and PvlCaD, respectively. Time course assays for the expressed proteins demonstrated that the optimum harvest time was 36 h postinfection. Immunofluorescence microscopy revealed PvlCaD localized on the plasma membrane of Sf9 cells at 24 h postinfection and distributed throughout the cytoplasm at 36-48 h postinfection. Analysis of the purified recombinant full-length CaD revealed most of the characteristics of the authentic CaD, including (a) an electrophoretic mobility corresponding to 125 kDa, (b) heat stability, (c) binding to actin, tropomyosin-actin, myosin, and calmodulin, (d) ability to inhibit actin-activated ATP hydrolysis by smooth muscle myosin, and (e) ability of Ca(2+)-calmodulin to reverse the inhibition. A CaD mutant with a deletion of 159 amino acids from the carboxyl terminus of the full-length CaD was also expressed at high levels in Sf9 cells. However, this mutant showed a decreased ability to bind to actin, tropomyosin-actin, and calmodulin, whereas the myosin binding was unaffected; actin-activated ATP hydrolysis by smooth muscle myosin was not inhibited by this mutant.
Similar articles
-
Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11899-904. doi: 10.1073/pnas.94.22.11899. Proc Natl Acad Sci U S A. 1997. PMID: 9342334 Free PMC article.
-
Characterization of the functional domains on the C-terminal region of caldesmon using full-length and mutant caldesmon molecules.J Biol Chem. 1996 Jan 26;271(4):2234-42. doi: 10.1074/jbc.271.4.2234. J Biol Chem. 1996. PMID: 8567684
-
Binding and regulatory properties of expressed functional domains of chicken gizzard smooth muscle caldesmon.J Biol Chem. 1993 May 25;268(15):10969-76. J Biol Chem. 1993. PMID: 8496161
-
Caldesmon: fragments, sequence, and domain mapping.Ann N Y Acad Sci. 1990;599:100-10. doi: 10.1111/j.1749-6632.1990.tb42368.x. Ann N Y Acad Sci. 1990. PMID: 2221667 Review.
-
Some properties of caldesmon and calponin and the participation of these proteins in regulation of smooth muscle contraction and cytoskeleton formation.Biochemistry (Mosc). 2001 Oct;66(10):1112-21. doi: 10.1023/a:1012480829618. Biochemistry (Mosc). 2001. PMID: 11736632 Review.
Cited by
-
Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11899-904. doi: 10.1073/pnas.94.22.11899. Proc Natl Acad Sci U S A. 1997. PMID: 9342334 Free PMC article.
-
Sarcomeric binding pattern of exogenously added intact caldesmon and its C-terminal 20-kDa fragment in skinned fibers of skeletal muscle.J Muscle Res Cell Motil. 1999 Apr;20(3):291-303. doi: 10.1023/a:1005490405222. J Muscle Res Cell Motil. 1999. PMID: 10471992
-
Regulation of actomyosin and contraction in smooth muscle.World J Urol. 1994;12(5):292-7. doi: 10.1007/BF00191210. World J Urol. 1994. PMID: 7866427 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous